Abstract
Júlia Martinková, Michaela Mihulová, Miroslava Balaščaková, Jan Trachta, Anna Křepelová
Abstract
Authors
Institutions
Provenance
crossref
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Ethical principles and recommendations for the medical management of differences of sex development (DSD)/intersex in children and adolescents
10.1007/s00431-009-1086-x · 2010
Consensus statement on management of intersex disorders. International consensus conference on intersex
10.1542/peds.2006-0738 · 2006
Consensus statement on management of intersex disorders
10.1136/adc.2006.098319 · 2006
Male pseudohermaphroditism: a hitherto undescribed form
10.1136/bmj.2.4941.709 · 1955
Swyer syndrome: presentation and outcomes
10.1111/j.1471-0528.2008.01703.x · 2008
case report: severe gonadal dysgenesis causing 46,XY disorder of sex development due to a novel NR5A1 variant
10.3389/fgene.2022.885589 · 2022
DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease
10.1016/j.beem.2015.07.004 · 2015
Genetics of 46,XY gonadal dysgenesis
10.1016/j.beem.2022.101633 · 2022
Gene mutations associated with anomalies of human gonad formation
10.1159/000342188 · 2012
Broad phenotypes in heterozygous NR5A1 46,XY patients with a disorder of sex development: an oligogenic origin?
Confidence 100%
openalex
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
10.1038/s41431-018-0202-7 · 2018
Mutational and functional studies on NR5A1 gene in 46,XY disorders of sex development: identification of six novel loss of function mutations
10.1016/j.fertnstert.2018.02.123 · 2018
Mutations in NR5A1 associated with ovarian insufficiency
10.1056/nejmoa0806228 · 2009
Ten novel mutations in the NR5A1 gene cause disordered sex development in 46,XY and ovarian insufficiency in 46,XX individuals
10.1210/jc.2011-3169 · 2012
Multifunctional role of steroidogenic factor 1 and disorders of sex development
10.1590/s0004-27302011000800015 · 2011
Structural characterization of human Ad4 bp (SF-1) gene
10.1006/bbrc.1996.1343 · 1996
Mutation update for the NR5A1 gene involved in DSD and infertility
10.1002/humu.23916 · 2020
Steroidogenic factor 1: a key determinant of endocrine development and function
10.1210/edrv.18.3.0301 · 1997
Molecular aspects of steroidogenic factor 1 (SF-1)
10.1016/j.mce.2009.07.003 · 2010
Steroidogenic factor 1 (NR5A1) resides in centrosomes and maintains genomic stability by controlling centrosome homeostasis
10.1038/cdd.2011.54 · 2011
A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation
10.1016/0092-8674(94)90211-9 · 1994
Steroidogenic factor-1 (SF-1, Ad4BP, NR5A1) and disorders of testis development
10.1159/000152036 · 2008
Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer
10.1038/nature06944 · 2008
Phenotype and molecular characterizations of 30 children from China with NR5A1 mutations
10.3389/fphar.2018.01224 · 2018
Minireview: steroidogenic factor 1: its roles in differentiation, development, and disease
10.1210/me.2009-0519 · 2010
Steroidogenic factor 1 (SF-1; NR5A1) regulates the formation of the ovarian reserve
10.1073/pnas.2220849120 · 2023
WNT4/beta-catenin Pathway maintains female germ cell survival by inhibiting activin betaB in the mouse fetal ovary
10.1371/journal.pone.0010382 · 2010
A versatile two-stage hypospadias repair
10.1016/s0007-1226(95)90023-3 · 1995
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology
10.1038/gim.2015.30 · 2015
Identification of NR5A1 mutations and possible digenic inheritance in 46,XY gonadal dysgenesis
10.1159/000445983 · 2016
Oligogenic analysis across broad phenotypes of 46,XY differences in sex development associated with NR5A1/SF-1 variants: findings from the international SF1next study
10.1016/j.ebiom.2025.105624 · 2025
Variants of STAR, AMH and ZFPM2/FOG2 may contribute towards the broad phenotype observed in 46,XY DSD patients with heterozygous variants of NR5A1
10.3390/ijms21228554 · 2020
Fertility preservation in a family with a novel NR5A1 mutation
10.1507/endocrj.ej14-0340 · 2015
Predominant sertoli cell deficiency in a 46,XY disorders of sex development patient with a new NR5A1/SF-1 mutation transmitted by his unaffected father
10.1016/j.fertnstert.2010.11.035 · 2011
Preserved fertility in a patient with a 46,XY disorder of sex development due to a new heterozygous mutation in the NR5A1/SF-1 gene: evidence of 46,XY and 46,XX gonadal dysgenesis phenotype variability in multiple members of an affected kindred
10.1159/000338346 · 2012
Disorders of sex development in a large Ukrainian cohort: clinical diversity and genetic findings
10.3389/fendo.2022.810782 · 2022
Consensus guide on prophylactic gonadectomy in different sex development
10.1016/j.endien.2022.10.002 · 2022
Gonadectomy in individuals with a difference of sex development—for whom, when, why, and why not?
10.1016/j.beem.2025.102019 · 2025
Gonadal malignancy risk and prophylactic gonadectomy in disorders of sexual development
10.1515/jpem-2014-0522 · 2015
Role of NR5A1 gene mutations in disorders of sex development: molecular and clinical features
10.3390/cimb46050274 · 2024
Spleen function is reduced in individuals with NR5A1 variants with or without a difference of sex development: a cross-sectional study
10.1093/ejendo/lvad174 · 2024
Management of 46,XY differences/disorders of sex development (DSD) throughout life
10.1210/er.2019-00049 · doi-reference
46, XY under-virilization and NR5A1 variants: monocentric Indian experience and systematic review
10.1016/j.ando.2025.101731 · doi-reference
Surgery in disorders of sex development (DSD) with a gender issue: if (why), when, and how?
10.1016/j.jpurol.2016.04.001 · doi-reference
Spleen function is reduced in individuals with NR5A1 variants with or without a difference of sex development: a cross-sectional study
10.1093/ejendo/lvad174 · doi-reference
Role of NR5A1 gene mutations in disorders of sex development: molecular and clinical features
10.3390/cimb46050274 · doi-reference
Gonadal malignancy risk and prophylactic gonadectomy in disorders of sexual development
10.1515/jpem-2014-0522 · doi-reference
Gonadectomy in individuals with a difference of sex development—for whom, when, why, and why not?
10.1016/j.beem.2025.102019 · doi-reference
Consensus guide on prophylactic gonadectomy in different sex development
10.1016/j.endien.2022.10.002 · doi-reference
Disorders of sex development in a large Ukrainian cohort: clinical diversity and genetic findings
10.3389/fendo.2022.810782 · doi-reference
Preserved fertility in a patient with a 46,XY disorder of sex development due to a new heterozygous mutation in the NR5A1/SF-1 gene: evidence of 46,XY and 46,XX gonadal dysgenesis phenotype variability in multiple members of an affected kindred
10.1159/000338346 · doi-reference
Predominant sertoli cell deficiency in a 46,XY disorders of sex development patient with a new NR5A1/SF-1 mutation transmitted by his unaffected father
10.1016/j.fertnstert.2010.11.035 · doi-reference
Fertility preservation in a family with a novel NR5A1 mutation
10.1507/endocrj.ej14-0340 · doi-reference
Variants of STAR, AMH and ZFPM2/FOG2 may contribute towards the broad phenotype observed in 46,XY DSD patients with heterozygous variants of NR5A1
10.3390/ijms21228554 · doi-reference
Oligogenic analysis across broad phenotypes of 46,XY differences in sex development associated with NR5A1/SF-1 variants: findings from the international SF1next study
10.1016/j.ebiom.2025.105624 · doi-reference
Identification of NR5A1 mutations and possible digenic inheritance in 46,XY gonadal dysgenesis
10.1159/000445983 · doi-reference
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology
10.1038/gim.2015.30 · doi-reference
A versatile two-stage hypospadias repair
10.1016/s0007-1226(95)90023-3 · doi-reference
WNT4/beta-catenin Pathway maintains female germ cell survival by inhibiting activin betaB in the mouse fetal ovary
10.1371/journal.pone.0010382 · doi-reference
Steroidogenic factor 1 (SF-1; NR5A1) regulates the formation of the ovarian reserve
10.1073/pnas.2220849120 · doi-reference
Minireview: steroidogenic factor 1: its roles in differentiation, development, and disease
10.1210/me.2009-0519 · doi-reference
Phenotype and molecular characterizations of 30 children from China with NR5A1 mutations
10.3389/fphar.2018.01224 · doi-reference
Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer
10.1038/nature06944 · doi-reference
Steroidogenic factor-1 (SF-1, Ad4BP, NR5A1) and disorders of testis development
10.1159/000152036 · doi-reference
A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation
10.1016/0092-8674(94)90211-9 · doi-reference
Steroidogenic factor 1 (NR5A1) resides in centrosomes and maintains genomic stability by controlling centrosome homeostasis
10.1038/cdd.2011.54 · doi-reference
Steroidogenic factor 1: a key determinant of endocrine development and function
10.1210/edrv.18.3.0301 · doi-reference
Mutation update for the NR5A1 gene involved in DSD and infertility
10.1002/humu.23916 · doi-reference
Structural characterization of human Ad4 bp (SF-1) gene
10.1006/bbrc.1996.1343 · doi-reference
Multifunctional role of steroidogenic factor 1 and disorders of sex development
10.1590/s0004-27302011000800015 · doi-reference
Ten novel mutations in the NR5A1 gene cause disordered sex development in 46,XY and ovarian insufficiency in 46,XX individuals
10.1210/jc.2011-3169 · doi-reference
Mutations in NR5A1 associated with ovarian insufficiency
10.1056/nejmoa0806228 · doi-reference
Mutational and functional studies on NR5A1 gene in 46,XY disorders of sex development: identification of six novel loss of function mutations
10.1016/j.fertnstert.2018.02.123 · doi-reference
Broad phenotypes in heterozygous NR5A1 46,XY patients with a disorder of sex development: an oligogenic origin?
10.1038/s41431-018-0202-7 · doi-reference
Gene mutations associated with anomalies of human gonad formation
10.1159/000342188 · doi-reference
Genetics of 46,XY gonadal dysgenesis
10.1016/j.beem.2022.101633 · doi-reference
DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease
10.1016/j.beem.2015.07.004 · doi-reference
case report: severe gonadal dysgenesis causing 46,XY disorder of sex development due to a novel NR5A1 variant
10.3389/fgene.2022.885589 · doi-reference
Swyer syndrome: presentation and outcomes
10.1111/j.1471-0528.2008.01703.x · doi-reference
Male pseudohermaphroditism: a hitherto undescribed form
10.1136/bmj.2.4941.709 · doi-reference
Consensus statement on management of intersex disorders
10.1136/adc.2006.098319 · doi-reference